IBDEI053 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6450,1,4,0)
 ;;=4^PNEUMONIA
 ;;^UTILITY(U,$J,358.3,6450,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,6451,0)
 ;;=590.80^^53^522^18
 ;;^UTILITY(U,$J,358.3,6451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6451,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,6451,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,6451,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,6452,0)
 ;;=711.00^^53^522^19
 ;;^UTILITY(U,$J,358.3,6452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6452,1,3,0)
 ;;=3^711.00
 ;;^UTILITY(U,$J,358.3,6452,1,4,0)
 ;;=4^SEPTIC JOINT
 ;;^UTILITY(U,$J,358.3,6452,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,6453,0)
 ;;=461.8^^53^522^20
 ;;^UTILITY(U,$J,358.3,6453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6453,1,3,0)
 ;;=3^461.8
 ;;^UTILITY(U,$J,358.3,6453,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,6453,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,6454,0)
 ;;=473.8^^53^522^21
 ;;^UTILITY(U,$J,358.3,6454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6454,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,6454,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,6454,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,6455,0)
 ;;=463.^^53^522^22
 ;;^UTILITY(U,$J,358.3,6455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6455,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,6455,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,6455,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,6456,0)
 ;;=011.90^^53^522^23
 ;;^UTILITY(U,$J,358.3,6456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6456,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,6456,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,6456,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,6457,0)
 ;;=465.9^^53^522^24
 ;;^UTILITY(U,$J,358.3,6457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6457,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,6457,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,6457,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,6458,0)
 ;;=599.0^^53^522^25
 ;;^UTILITY(U,$J,358.3,6458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6458,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,6458,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,6458,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,6459,0)
 ;;=616.10^^53^522^26
 ;;^UTILITY(U,$J,358.3,6459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6459,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,6459,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,6459,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,6460,0)
 ;;=277.30^^53^523^1
 ;;^UTILITY(U,$J,358.3,6460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6460,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,6460,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,6460,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,6461,0)
 ;;=277.31^^53^523^3
 ;;^UTILITY(U,$J,358.3,6461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6461,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,6461,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,6461,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,6462,0)
 ;;=277.39^^53^523^2
 ;;^UTILITY(U,$J,358.3,6462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6462,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,6462,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,6462,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,6463,0)
 ;;=446.21^^53^523^4
 ;;^UTILITY(U,$J,358.3,6463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6463,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,6463,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,6463,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,6464,0)
 ;;=580.0^^53^523^8
 ;;^UTILITY(U,$J,358.3,6464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6464,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,6464,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,6464,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,6465,0)
 ;;=580.4^^53^523^9
 ;;^UTILITY(U,$J,358.3,6465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6465,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,6465,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,6465,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,6466,0)
 ;;=580.9^^53^523^7
 ;;^UTILITY(U,$J,358.3,6466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6466,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,6466,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,6466,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,6467,0)
 ;;=582.0^^53^523^14
 ;;^UTILITY(U,$J,358.3,6467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6467,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,6467,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,6467,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,6468,0)
 ;;=582.1^^53^523^12
 ;;^UTILITY(U,$J,358.3,6468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6468,1,3,0)
 ;;=3^582.1
 ;;^UTILITY(U,$J,358.3,6468,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,6468,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,6469,0)
 ;;=582.2^^53^523^11
 ;;^UTILITY(U,$J,358.3,6469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6469,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,6469,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,6469,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,6470,0)
 ;;=582.4^^53^523^15
 ;;^UTILITY(U,$J,358.3,6470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6470,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,6470,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,6470,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,6471,0)
 ;;=582.81^^53^523^10
 ;;^UTILITY(U,$J,358.3,6471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6471,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,6471,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,6471,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,6472,0)
 ;;=582.9^^53^523^13
 ;;^UTILITY(U,$J,358.3,6472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6472,1,3,0)
 ;;=3^582.9
 ;;^UTILITY(U,$J,358.3,6472,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,6472,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,6473,0)
 ;;=583.81^^53^523^5
 ;;^UTILITY(U,$J,358.3,6473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6473,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,6473,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,6473,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,6474,0)
 ;;=583.81^^53^523^16
 ;;^UTILITY(U,$J,358.3,6474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6474,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,6474,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,6474,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,6475,0)
 ;;=583.9^^53^523^6
 ;;^UTILITY(U,$J,358.3,6475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6475,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,6475,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,6475,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,6476,0)
 ;;=710.0^^53^523^17
 ;;^UTILITY(U,$J,358.3,6476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6476,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,6476,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,6476,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,6477,0)
 ;;=582.89^^53^524^2
 ;;^UTILITY(U,$J,358.3,6477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6477,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,6477,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,6477,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,6478,0)
 ;;=580.89^^53^524^1
 ;;^UTILITY(U,$J,358.3,6478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6478,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,6478,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,6478,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,6479,0)
 ;;=583.89^^53^524^3
 ;;^UTILITY(U,$J,358.3,6479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6479,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,6479,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,6479,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,6480,0)
 ;;=042.^^53^525^1
 ;;^UTILITY(U,$J,358.3,6480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6480,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,6480,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,6480,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6481,0)
 ;;=581.1^^53^525^2
 ;;^UTILITY(U,$J,358.3,6481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6481,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,6481,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
 ;;^UTILITY(U,$J,358.3,6481,2)
 ;;=^270344
 ;;^UTILITY(U,$J,358.3,6482,0)
 ;;=581.2^^53^525^3
 ;;^UTILITY(U,$J,358.3,6482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6482,1,3,0)
 ;;=3^581.2
 ;;^UTILITY(U,$J,358.3,6482,1,4,0)
 ;;=4^NEPHROSIS MEMBRANOPROL
 ;;^UTILITY(U,$J,358.3,6482,2)
 ;;=^270345
 ;;^UTILITY(U,$J,358.3,6483,0)
 ;;=581.3^^53^525^4
 ;;^UTILITY(U,$J,358.3,6483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6483,1,3,0)
 ;;=3^581.3
 ;;^UTILITY(U,$J,358.3,6483,1,4,0)
 ;;=4^NEPHROSIS,MINIMAL CHANGE
 ;;^UTILITY(U,$J,358.3,6483,2)
 ;;=^82320
 ;;^UTILITY(U,$J,358.3,6484,0)
 ;;=581.9^^53^525^5
 ;;^UTILITY(U,$J,358.3,6484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6484,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,6484,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,6484,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,6485,0)
 ;;=446.0^^53^525^6
 ;;^UTILITY(U,$J,358.3,6485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6485,1,3,0)
 ;;=3^446.0
 ;;^UTILITY(U,$J,358.3,6485,1,4,0)
 ;;=4^POLYARTERITIS
 ;;^UTILITY(U,$J,358.3,6485,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,6486,0)
 ;;=581.81^^53^525^7
 ;;^UTILITY(U,$J,358.3,6486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6486,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,6486,1,4,0)
 ;;=4^SECONDARY NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,6486,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,6487,0)
 ;;=710.0^^53^525^8
 ;;^UTILITY(U,$J,358.3,6487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6487,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,6487,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,6487,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,6488,0)
 ;;=596.0^^53^526^1
 ;;^UTILITY(U,$J,358.3,6488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6488,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,6488,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,6488,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,6489,0)
 ;;=592.0^^53^526^2
 ;;^UTILITY(U,$J,358.3,6489,1,0)
 ;;=^358.31IA^4^2
